Controversy of the prostate-specific antigen test era: should prostate cancer be detected and treated in all patients?
摘要The United States Food and Drug Administration approved the prostate-specific antigen (PSA) test in 1986 for monitoring the progression of prostate cancer;in 1994,the test was approved for the early detection of prostate cancer.1 The application of the PSA test has significantly increased the detection rate of prostate cancer.
更多相关知识
- 浏览132
- 被引1
- 下载4

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



